Nidhi Jain, MD
Endocrinology, Diabetes & Metabolism · Little Rock, ARNPI 1306936877
Payments from drug & device makers
Across 479 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Dexcom, Inc.$847
- Stimwave Technologies Incorporated$620
- Abbott$533
- Sanofi-aventis U.S. LLC$502
- Lilly USA, LLC$501
- plus $5K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $1,134 |
| Dexcom, Inc. | 60 | $847 |
| Stimwave Technologies Incorporated | 5 | $620 |
| Abbott | 30 | $533 |
| Sanofi-aventis U.S. LLC | 35 | $502 |
| Lilly USA, LLC | 28 | $501 |
| Boehringer Ingelheim | 33 | $437 |
| Amgen(2 entities) | 28 | $437 |
| Xeris Pharmaceuticals, Inc. | 13 | $427 |
| Bayer | 26 | $415 |
| AbbVie | 19 | $388 |
| Medtronic(2 entities) | 8 | $378 |
| Insulet Corporation | 22 | $353 |
| Cequr Corporation | 2 | $254 |
| Tandem Diabetes Care, Inc. | 14 | $246 |
| Kyowa Kirin, Inc. | 3 | $197 |
| Corcept Therapeutics | 5 | $105 |
| Nevro Corp. | 6 | $100 |
| Ascendis Pharma Endocrinology Inc | 5 | $89 |
| Recordati_rare_diseases_inc. | 4 | $79 |
| Novartis | 4 | $75 |
| BETA Bionics, Inc. | 5 | $73 |
| AstraZeneca | 5 | $72 |
| Shire North American Group Inc | 4 | $67 |
| Valeritas, Inc. | 2 | $47 |
| Chiesi USA, Inc. | 2 | $43 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Antares Pharma, Inc. | 2 | $40 |
| Sequel Med Tech, LLC | 2 | $37 |
| Johnson & Johnson | 3 | $36 |
| Radius Health, Inc. | 1 | $32 |
| Averitas Pharma Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Boston Scientific | 1 | $28 |
| BD | 1 | $22 |
| Almatica Pharma LLC | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lifescan, Inc. | 1 | $11 |
How this compares
$8,792 in reported general payments places this provider in the 55th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.
See all endocrinology, diabetes & metabolism providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Little Rock
- James ThrasherLittle Rock$4M
- Richard GriffithsLittle Rock$925K
- Madhu BudhrajaLittle Rock$461K
- Irina LendelLittle Rock$87K
- Donald BodennerLittle Rock$51K
- Richard RappLittle Rock$47K
- Shunzhong BaoLittle Rock$40K
- Teresa NimmoLittle Rock$29K
- Joseph HenskeLittle Rock$23K
- Archana JarathiLittle Rock$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.